Dutch electronics giant Philips said on Friday it was buying US remote cardiac monitoring firm BioTelemetry for $2.8 billion (€2.3bn).

The purchase comes as Philips, formerly best known for home appliances, moves into health equipment sales.

“The acquisition of BioTelemetry fits perfectly with our strategy to be a leading provider of patient care management solutions for the hospital and the home,” said Philips chief executive Frans van Houten in a statement.

BioTelemetry focuses on wearable heart monitors for the diagnosis and monitoring of heart rhythm disorders, with over a million patients a year, Philips said.

Amsterdam-based Philips said it would buy all outstanding BioTelemetry shares at $72.00 per share.

Philips sold off its home appliance arm in January to fully concentrate on health sector products.

Philips sold off its home appliance arm in January to fully concentrate on health sector products

It has particularly focused on tele-health care for patients outside hospitals.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.